Annual Drug Patent Expirations for LEXAPRO
Lexapro is a drug marketed by Allergan and is included in two NDAs. It is available from two suppliers. There are two patents protecting this drug and two Paragraph IV challenges.
The generic ingredient in LEXAPRO is escitalopram oxalate. Two suppliers are listed for this compound. Additional details are available on the escitalopram oxalate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com